Atlas Trials

Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type IIIA

Clinical trial NCT04201405 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04201405
Sponsor
University of Manchester
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis Type IIIA
Start date
2020-01-07
Primary completion
2024-10-30
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.